This page shows Oxford Square (OXSQG) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
We are recalculating Oxford Square's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.
Oxford Square passes 1 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
Oxford Square reported a net loss of $18.7M while operations used $13.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Oxford Square reported -$18.7M in net income in fiscal year 2025. This represents a decrease of 418.6% from the prior year.
Oxford Square earned $0.30 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 28.6% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Oxford Square held $51.9M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Oxford Square's ROE was -12.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 16.5 percentage points from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Capital Allocation
None of these metrics is reported for fiscal year 2025.
OXSQG Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|---|
| SG&A Expenses | N/A | $616K+3.0% | $598K-6.3% | $638K+9.4% | $584K+11.9% | $522K-11.8% | $592K |
| Interest Expense | N/A | $9.2M+17.8% | $7.8M-27.5% | $10.8M-12.4% | $12.4M+17.7% | $10.5M+33.2% | $7.9M |
| Net Income | N/A | -$18.7M-418.6% | $5.9M-65.9% | $17.2M+120.1% | -$85.6M-316.1% | $39.6M | N/A |
| EPS (Diluted) | — | $0.30-28.6% | $0.42 | $0.51+21.4% | $0.42+31.2% | $0.32 | N/A |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, Income Tax.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
OXSQG Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|
| Total Assets | $306.7M+2.3% | $299.7M+7.9% | $277.7M-15.3% | $328.0M-24.3% | $433.5M | N/A |
| Cash & Equivalents | $51.9M+48.7% | $34.9M+508.4% | $5.7M-36.4% | $9.0M0.0% | $9.0M-84.8% | $59.1M |
| Total Liabilities | $161.3M+16.0% | $139.1M+10.1% | $126.4M-33.3% | $189.3M+0.2% | $188.9M | N/A |
| Long-Term Debt | N/A | N/A | $127.5M | N/A | N/A | N/A |
| Total Equity | $145.4M-9.5% | $160.7M+6.2% | $151.3M+9.1% | $138.7M-43.3% | $244.6M+8.5% | $225.4M |
| Retained Earnings | -$378.5M-15.4% | -$328.0M-6.7% | -$307.4M-3.7% | -$296.6M | N/A | N/A |
Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities.
OXSQG Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$34.1M | -$13.7M-153.4% | $25.7M-60.8% | $65.5M+221.5% | $20.4M+119.0% | -$107.4M-213.0% | $95.1M |
| Financing Cash Flow | $37.8M | $30.7M+784.2% | $3.5M+105.1% | -$68.8M-237.7% | -$20.4M-135.5% | $57.3M+209.4% | -$52.4M |
| Dividends Paid | $33.1M | $31.3M+21.6% | $25.8M-10.0% | $28.6M+40.5% | $20.4M-0.2% | $20.4M-32.2% | $30.1M |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Investing Cash Flow, Share Buybacks.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
OXSQG Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|
| Return on Equity | -12.9%-16.5pp | 3.7%-7.7pp | 11.4%+73.1pp | -61.7%-77.9pp | 16.2% | N/A |
| Return on Assets | -6.1%-8.1pp | 2.0%-4.3pp | 6.2%+32.3pp | -26.1%-35.2pp | 9.1% | N/A |
| Debt-to-Equity | 1.11+0.2x | 0.870.0x | 0.84-0.5x | 1.37+0.6x | 0.77 | N/A |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Current Ratio, FCF Margin.
Where Oxford Square Ranks
Frequently Asked Questions
Is Oxford Square profitable?
No, Oxford Square (OXSQG) reported a net income of -$18.7M in fiscal year 2025.
What is Oxford Square's return on equity (ROE)?
Oxford Square (OXSQG) has a return on equity of -12.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Oxford Square's operating cash flow?
Oxford Square (OXSQG) recorded an outflow of $13.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Oxford Square's total assets?
Oxford Square (OXSQG) had $306.7M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Oxford Square's debt-to-equity ratio?
Oxford Square (OXSQG) had a debt-to-equity ratio of 1.11 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Oxford Square's return on assets (ROA)?
Oxford Square (OXSQG) had a return on assets of -6.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Oxford Square's cash runway?
Based on fiscal year 2025 data, Oxford Square (OXSQG) had $51.9M in cash against an annual operating cash burn of $13.7M. This gives an estimated cash runway of approximately 45 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Oxford Square's Piotroski F-Score?
Oxford Square (OXSQG) has a Piotroski F-Score of 1 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Oxford Square's earnings high quality?
Oxford Square (OXSQG) reported a net loss of $18.7M while operations used $13.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.